Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma

doi:10.3748/wjg.v17.i41.4563

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 41

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7446)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

479

HTML

6472

Figures (1-4)

309

Tables (1-2)

186

Sum=7446

Nov 7, 2011 (publication date) through Jul 21, 2024

Times Cited of This Article

Times Cited (44)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Nov 7, 2011; 17(41): 4563-4571
Published online Nov 7, 2011. doi: 10.3748/wjg.v17.i41.4563

Full Size Figure Download Figure

Figure 2 Expression of alpha fetoprotein and alpha fetoprotein receptor in HepG2 and HLE cells. A: Western blotting; B and C: Confocal microscopy. The immunoblots and images captured by cofocal microscopy are representative of experiments that were repeated at least three times. AFP: Alpha fetoprotein; AFPR: Alpha fetoprotein receptor.

Citation: Li P, Wang SS, Liu H, Li N, McNutt MA, Li G, Ding HG. Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma. World J Gastroenterol 2011; 17(41): 4563-4571
URL: https://www.wjgnet.com/1007-9327/full/v17/i41/4563.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i41.4563